Innovative Product Development Xeris Pharmaceuticals is actively developing advanced therapies, including a glucagon product for proprietary pump technology, indicating strong potential for collaborations in drug delivery systems and medical device integrations.
Strategic Leadership Expansion Recent high-profile hires such as Dr. Anh Nguyen as SVP, Global Development and Medical Affairs, suggest a focus on expanding clinical and medical expertise, creating opportunities for partnerships in clinical research and medical affairs services.
Financial Growth Potential With revenues estimated between $100M and $250M and a recent funding round of $200M, Xeris demonstrates financial stability and growth capacity, making it attractive for investment in manufacturing, distribution, and supportive healthcare technologies.
Industry Engagement Active participation in healthcare conferences and awards, such as the ADCES Awards and Piper Sandler Healthcare Conference, positions Xeris as an influential player, offering opportunities for collaboration with industry leaders and access to innovative healthcare solutions.
Technology Utilization The company's use of advanced tech stacks including Veeva Vault, SAP Concur, and Akamai indicates a focus on digital transformation, which could open doors for sales of enterprise software, cybersecurity, and cloud solutions tailored for biopharmaceutical operations.
$100M$250M
$1B$10B
$10B
$10B
$10B
$10BXeris Pharmaceuticals, Inc. uses 8 technology products and services including Akamai, Veeva Vault, Microsoft, and more. Explore Xeris Pharmaceuticals, Inc.'s tech stack below.
| Xeris Pharmaceuticals, Inc. Email Formats | Percentage |
| FLast@xerispharma.com | 95% |
| Last@xerispharma.com | 3% |
| FMiddleLast@xerispharma.com | 1% |
| FirstL@xerispharma.com | 1% |
Pharmaceutical ManufacturingIllinois, United States201-500 Employees
We're a growth-oriented biopharmaceutical company improving patient lives by developing and commercializing advanced products across a range of therapies.
Company Overview
Funding & FinancialsXeris Pharmaceuticals, Inc. has raised a total of $200M of funding over 14 rounds. Their latest funding round was raised on Mar 06, 2024 in the amount of $200M.
Xeris Pharmaceuticals, Inc.'s revenue is estimated to be in the range of $100M$250M
Funding & FinancialsXeris Pharmaceuticals, Inc. has raised a total of $200M of funding over 14 rounds. Their latest funding round was raised on Mar 06, 2024 in the amount of $200M.
Xeris Pharmaceuticals, Inc.'s revenue is estimated to be in the range of $100M$250M
1-888-653-2347 
support@leadiq.com